16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Neonatal Fc receptor expression in dendritic cells mediates protective immunity against colorectal cancer.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Cancers arising in mucosal tissues account for a disproportionately large fraction of malignancies. Immunoglobulin G (IgG) and the neonatal Fc receptor for IgG (FcRn) have an important function in the mucosal immune system that we have now shown extends to the induction of CD8(+) T cell-mediated antitumor immunity. We demonstrate that FcRn within dendritic cells (DCs) was critical for homeostatic activation of mucosal CD8(+) T cells that drove protection against the development of colorectal cancers and lung metastases. FcRn-mediated tumor protection was driven by DCs activation of endogenous tumor-reactive CD8(+) T cells via the cross-presentation of IgG complexed antigens (IgG IC), as well as the induction of cytotoxicity-promoting cytokine secretion, particularly interleukin-12, both of which were independently triggered by the FcRn-IgG IC interaction in murine and human DCs. FcRn thus has a primary role within mucosal tissues in activating local immune responses that are critical for priming efficient anti-tumor immunosurveillance.

          Related collections

          Author and article information

          Journal
          Immunity
          Immunity
          Elsevier BV
          1097-4180
          1074-7613
          Dec 12 2013
          : 39
          : 6
          Affiliations
          [1 ] Gastroenterology Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
          [2 ] Department of Medicine, Pharmacology and Immunology-Microbiology, University of North Carolina at Chapel Hill, NC 27599, USA.
          [3 ] GI Pathology, Caris Diagnostics, Caris Life Sciences, Newton, MA 02464, USA.
          [4 ] University of Bern, Institute of Pathology, Translational Research Unit, 3010 Bern, Switzerland.
          [5 ] Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
          [6 ] Harvard Digestive Diseases Center, Boston, MA 02115, USA; Division of Gastroenterology and Nutrition, Children's Hospital Boston and the Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA.
          [7 ] Department of Infectious Diseases & Pathology, College of Medicine, Department of Medicine, Division of Gastroenterology, Hepatology & Nutrition, Gainesville, FL 32611, USA.
          [8 ] Gastroenterology Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Harvard Digestive Diseases Center, Boston, MA 02115, USA. Electronic address: rblumberg@partners.org.
          Article
          S1074-7613(13)00502-5 NIHMS545416
          10.1016/j.immuni.2013.11.003
          3902970
          24290911
          4bb08fe2-9680-4850-a09e-b05b291511e9
          History

          Comments

          Comment on this article